Completed PHASE1 INTERVENTIONAL 2-arm NCT04391478

Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension (ESMPPHTN)

Milrinone Versus Sildenafil in Treatment of PPHN in Neonates

Sponsor: Rania Ali El-Farrash

Conditions Persistent Pulmonary Hypertension

Updated 4 times since 2020 Last updated: May 14, 2020 Started: Jan 31, 2015 Primary completion: Apr 30, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Persistent Pulmonary Hypertension and is currently completed. Rania Ali El-Farrash leads this study, which shows 4 recorded versions since 2015 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2020 — Jan 2021 [monthly]

Completed PHASE1

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rania Ali El-Farrash

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.